aTyr Pharma Inc. share price logo

aTyr Pharma Inc.

NASDAQ: ATYR

Small Cap

$0.53

-0.03

(-5.75%)

as on

aTyr Pharma Inc. Stock Performance

as on June 27, 2026 at 2:15 pm IST

  • Day's Low

    Day's High

    $0.52
    $0.58
    downward going graph

    1.89%

    Downside

    9.43%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $0.40
    $7.29
    downward going graph

    25.47%

    Downside

    1275.55%

    Upside

    downward going graph

aTyr Pharma Inc. share price movements today

Previous Close
$0.56
Open
$0.55
Volume
2.7M
Day's Low - High
$0.52 - $0.58
52 Week Low - High
$0.40 - $7.29

aTyr Pharma Inc. Historical Returns

1 Month Return
+ 15.57 %
3 Month Return
-29.39 %
1 Year Return
-89.46 %
3 Year Return
0 %
5 Year Return
0 %

aTyr Pharma Inc. Stock Fundamentals & Key Indicators

Check aTyr Pharma Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$55.1M

EPS (TTM)

-0.5233

Dividend Yield

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

Return On Equity TTM

-105.63%

aTyr Pharma Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of aTyr Pharma Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
NA$55.1MNANA0.00%NA
BUY$39.3B67.15%74.0712.55%NA
BUY$120.6B147.08%28.1735.51%NA
BUY$65.4B12.64%15.2229.65%0.58%

Stock Returns calculator for aTyr Pharma Inc. Stock including INR - Dollar returns

The aTyr Pharma Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

aTyr Pharma Inc. investment value today

Current value as on today

₹10,990

Returns

-₹89,010

(-89.01%)

Returns from aTyr Pharma Inc. Stock

-₹90,019 (-90.02%)

Dollar Impact

₹1,009 (+1.01%)

Indian Investors' Interest in aTyr Pharma Inc. Stock

Search interest for aTyr Pharma Inc. Stock has decreased by -30% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-30% versus previous 30 day period

aTyr Pharma Inc. Quarterly Profit & Loss

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Total Revenue
-
0
-
-
-
-
-
0
-
-
Gross Profit
0
0
0
0
-12
0
0
-21
0
0
Operating Income
-15
-16
-17
-18
-15
-15
-20
-26
-14
-11
EBITDA
-14
-14
-15
-16
-14
-14
-19
-25
-13
-10
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-14
-15
-16
-17
-14
-14
-19
-25
-13
-10
Income Tax Expense
0
0
0
-
-
-
-
-
-
-
Net Income
-14
-15
-16
-17
-14
-14
-19
-25
-13
-10
Net Profit Margin
0.00%
-6591.91%
0.00%
0.00%
0.00%
0.00%
0.00%
-13549.47%
0.00%
0.00%

aTyr Pharma Inc. Annual Profit & Loss

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
0
10
-
10
0
0
0
Gross Profit
-13
-6
-1
8
0
0
-1
Operating Income
-22
-15
-34
-46
-54
-67
-77
EBITDA
-22
-14
-32
-43
-47
-62
-72
Interest Expense
-
-
-
-
-
-
-
Depreciation
-
1
1
1
2
1
1
Income Before Tax
-23
-16
-33
-45
-50
-64
-74
Income Tax Expense
0
0
0
0
0
-
-
Net Income
-23
-16
-33
-45
-50
-64
-74
Net Profit Margin
-5593.13%
-155.18%
0.00%
-436.53%
-14274.50%
-27243.83%
-39009.47%

aTyr Pharma Inc. Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Net Income
-15
-16
-17
-14
-14
-19
-25
-13
-10
Operating Cash Flow
-22
-20
-13
-13
-15
-13
-20
-12
-12
Investing Cash Flow
-1
6
17
-6
-4
3
-20
16
11
Financing Cash Flow
7
13
0
18
18
17
29
0
0
Change in Cash
-15
0
4
0
-1
7
-11
4
-1

aTyr Pharma Inc. Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-48
-34
-23
-16
-33
-45
-50
-64
-74
Operating Cash Flow
-42
-31
-20
-15
-33
-41
-33
-69
-61
Investing Cash Flow
-27
37
4
6
-91
47
-20
17
-5
Financing Cash Flow
52
-4
1
16
110
5
66
39
66
Change in Cash
-17
1
-13
7
-14
10
12
-12
-1

Global Institutional Holdings in aTyr Pharma Inc.

Funds
Holdings
Two Sigma Advisers, LLC
0.86%
Vanguard Portfolio Management, LLC
0.58%
UBS Group AG
3.94%
Bank of New York Mellon Corp
0.2%
Vanguard Capital Management, LLC
3.89%

aTyr Pharma Inc. News & Key Events

  • img

    Today's Timeline - 15 September

    Mon, 08:28 PM

    -

    Atyr Pharma stock plummets 80.76% after Phase 3 trial fails primary endpoint for efzofitimod in pulmonary sarcoidosis.

Insights on aTyr Pharma Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, ATYR stock has moved up by 17.1%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Regeneron Pharmaceuticals, Inc. Common Stock has given 21.5% return, outperforming this stock by 111.0%

About aTyr Pharma Inc.

aTyr Pharma, Inc., a clinical stage biotechnology company, engages in the discovery and development of product candidates that translate tRNA synthetase biology into new therapies for fibrosis and inflammation in the United States. Its lead therapeutic candidate efzofitimod, a selective modulator of NRP2 that is in Phase 3 clinical trial for the treatment of pulmonary sarcoidosis; Phase 2 clinical trial to treat Sarcoidosis and systemic sclerosis- interstitial lung disease (ILDs); and treatment of other ILDs, such as chronic hypersensitivity pneumonitis (CHP) and connective tissue disease related ILD. The company is developing ATYR0101, a fusion protein derived from a domain of aspartyl-tRNA synthetase, which is in preclinical development for the treatment of fibrosis; and ATYR0750, a domain of alanyl-tRNA synthetase for the treatment of liver disorders. It has collaboration and license agreement with Kyorin Pharmaceutical Co., Ltd. for the development and commercialization of efzofitimod for ILDs in Japan. aTyr Pharma, Inc. was incorporated in 2005 and is headquartered in San Diego, California.
OrganisationaTyr Pharma Inc.
Headquarters10240 Sorrento Valley Road, San Diego, CA, United States, 92121
IndustryBiotechnology
CEODr. Sanjay S. Shukla M.D., M.S.
E-voting on sharesClick here to vote

Key Management of aTyr Pharma Inc.

Name

Title

Mr. Peter Villiger

Vice President of Corporate Development

Ms. Danielle Campbell

VP of Human Resource

Ms. Dalia R. Rayes M.B.A.

Head of Commercial, Global Efzofitimod Franchise

Dr. Leslie Nangle Ph.D.

Vice President of Research

Dr. Sanjay S. Shukla M.D., M.S.

President, CEO & Director

Ms. Jill M. Broadfoot CPA

Chief Financial Officer

Ms. Nancy E. Denyes Krueger J.D.

General Counsel & Corporate Secretary

Ms. Ashlee Dunston

Director of Investor Relations & Corporate Communications

FAQs

What is aTyr Pharma Inc. share price today?

aTyr Pharma Inc. share price today is $0.53 as on at the close of the market. aTyr Pharma Inc. share today touched a day high of $0.58 and a low of $0.52.

What is the 52 week high and 52 week low for aTyr Pharma Inc. share?

aTyr Pharma Inc. share touched a 52 week high of $7.29 on and a 52 week low of $0.4 on . aTyr Pharma Inc. stock price today i.e. is closed at $0.53,which is 92.73% down from its 52 week high and 34.18% up from its 52 week low.

What is aTyr Pharma Inc.'s market capitalisation today?

aTyr Pharma Inc. market capitalisation is $0.00T as on .

How to invest in aTyr Pharma Inc. Stock (ATYR) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for aTyr Pharma Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in aTyr Pharma Inc. Shares that will get you 2.8302 shares as per aTyr Pharma Inc. share price of $0.53 per share as on June 27, 2026 at 8:45 am IST.

What is the minimum amount required to buy aTyr Pharma Inc. Stock (ATYR) from India?

Indian investors can start investing in aTyr Pharma Inc. (ATYR) shares with as little as ₹94.3 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹943.00 in aTyr Pharma Inc. stock (as per the Rupee-Dollar exchange rate as on ). Based on aTyr Pharma Inc. share’s latest price of $0.53 as on June 27, 2026 at 8:45 am IST, you will get 18.8679 shares of aTyr Pharma Inc.. Learn more about fractional shares .